You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CBIO Sale Disclosure
Brumm Joshua T · SEC Form 4 · Filed Sep 18, 2026
Sale
Calculated transaction value
$28.82K
Brumm Joshua T Chief Executive Officer
CBIO
Transaction date
Sep 16, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 2 days later
CBIO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 1,610 shares @ $17.9
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-062701
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$159.78K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crescent Biopharma, Inc. CBIO | Sale | Sep 18, 2026 | $130.96K |
| Crescent Biopharma, Inc. CBIO Current | Sale | Sep 16, 2026 | $28.82K |